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ABSTRACT
Periodontitis is a periodontal disease involving the gingiva, periodontal ligament, cementum, and alveolar bone due to 
an inflammatory process. Virulence factors of periodontopathogens and inflammatory responses in periodontitis can 
stimulate nuclear factor-kappa B (NF-κB) activity. Charantoside c and Momordicosides g in bitter gourd prevent NF-κB 
activation stimulated by TNF-α in HepG2 cells. This study aims to determine the effect of bitter gourd fruit (Momordica 
charantia) ethanolic extract as an anti-inflammatory substance on the level of inflammatory infiltrates and the number of 
cells that experience NF-κB activation in the periodontitis model. Eighty male Wistar rats were divided into 5 groups. The 
mandibular incisors were ligated for 14 days to induce periodontitis. Each group was given Momordica charantia extract 
of 500 mg/kg BW, 250 mg/kg BW, and 100 mg/kg BW; ibuprofen 100 mg/kg BW; and aquades orally using oral gavage 
on the day 14. Rat necropsy was carried out on day 1, 3, 5, and 7 after giving the substances. Taking out the lower jaw 
was done to make tissue preparations followed by staining them with hematoxylin eosin (HE). Immunohistochemical 
analysis was performed to observe cells that were positive for NF-κB activation. The results showed a decrease in the 
density of inflammatory infiltrates in all groups, except for those given aquades. The number of inflammatory cells of 
neutrophils, macrophages, and lymphocytes that experienced NF-κB activation showed the most effective decrease in 
the group of Momordica charantia 500 mg/kg BW, on the 7th day. The conclusion of this study is that ethanolic extract 
of Momordica charantia has an anti-inflammatory effect and prevents the activation of NF-kB in rat gingival induced by 
periodontitis. The highest effect was found at a dose of 500 mg/kg BW on day 7 after giving of extracts. 
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INTRODUCTION
Periodontitis is a chronic inflammatory disease 
as a tissue response to periodontopathogenic 
bacteria that remain in gingival tissue. The 
response results in changes in the gingival tissue or 
developments causing damage to the periodontal 
tissue, accompanied by loss of bone attachment 
and damage.1 Inflammatory cells that play a 
role in periodontal disease include neutrophils, 
macrophages, and lymphocytes.2
Previous studies have shown that the causes 
of periodontal disease are periodontopathogenic 
bacteria, such as: Porphyromonas gingivalis 
(P. gingivalis), Aggregatibacter actinomycetemco­
mitans (A. Actinomicetemcomitans), Tannerella 
forsyithia, Prevotella nigriscens, Parvimonas micra, 
Fuso bac terium nucleatum and Campilobacter 
rectus.3 Analysis results of reverse transcription 
poly merase chain reaction (RT-PCR) in the control 
group of Wistar rats induced by periodontitis using 
ligature yarn showed A. actinomicetemcomitans 
involvement by 36% and P. gingivalis by 60%.4
Nuclear factor – kappa B (NF-κB) is a 
transcription factor that plays an important 
role in the regulation of the immune system in 
the inflammatory process. Lipopolysaccharide 
(LPS) released by periodontopathogens such 
as A. actinomicetemcomitans and P. gingivalis 
in periodontitis, play an important role in NF-κB 
activation. When periodontopathogenic infections 
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occur, these bacteria activate the NF-κB transcription 
factor through Toll Like Receptor (TLR) stimulation, 
which is expressed in nonspecific immune cells, 
including macrophage cells, dendritic, and mucosal 
epithelium.5
Bitter gourd plant (Momordica charantia) 
is beneficial to the health of the human body. It 
(Momordica charantia) can be used as traditional 
medicine in the treatment of several diseases, as 
well as in inflammatory conditions.6,7 The use of 
Momordica charantia in mice with a high-fat diet 
reduced inflammatory indicators.8 Water-ethanol 
extract of Momordica charantia suppressed NF-κB 
activity.9 The Momordica charantia also reduced 
levels of Prostaglandin E2 (PGE2), Interleukin 
1β (IL-1β), Interleukin 6 (IL-6), Interleukin 7 (IL-
7), Tumor Necrosis Factor α (TNFα), and, and 
increased the secretion of Transforming Growth 
Factor β (TGF-β), Interleukin 10 (IL-10).7
The main bioactive component in the 
Momordica charantia, which is anti-inflammatory 
is the Curcubitance-type triterpen glicosides. 
Nhiem et al.7 conducted a study of 17 types of 
Curcubitance-type triterpen glicosides isolated 
from Momordica charantia. Of these 17 types, type 
6 (Charantoside c) and type 8 (Momordicosides G) 
were found to prevent NF-κB activation stimulated 
by TNFα in HepG2 cells.7 The purpose of this study 
is is to determine the effect of ethanolic extract 
of bitter gourd fruit (Momordica charantia) as an 
anti-inflammatory substance by analyzing density 
levels of inflammatory infiltrate and number of cells 
undergoing NF-κB activation in the Wistar rats’ 
periodontitis model.
MATERIALS AND METHODS
All research procedures have been approved by 
the ethics committee of the Faculty of Dentistry, 
Universitas Gadjah Mada, Yogyakarta with the 
issuance of number ethical clearance clearance 
certificate No: 00768/KKEP/FKG-UGM/EC/2016. 
Eighty male Wistar rats were divided into 5 groups, 
each group consisted of 4 rats on each observation 
day (1, 3, 5, and 7 days after treatment). 
Before the induction of periodontitis, the mice 
were anesthetized using ketamine HCl 1 ml/kg BW 
on the intramuscular. The induction of periodontitis 
in mice was was done by wrapping a ligature from 
silk (silk ligature) size 3.0 around the bottom edge of 
the lower gingiva of the mandibular anterior incisor.10 
Ligation was checked every day until the 14th day 
of attachment. On the 15th day, each group was 
given Momordica charantia extract of of 500 mg/kg 
BW, 250 mg/kg BW, and 100 mg/kg BW, ibuprofen 
100 mg/kg BW, and aquades. The administration 
of Momordica charantia extract, ibuprofen, and 
aquades was done orally using 5 mL of oral gavage 
3 times a day. Rats were sacrificed on days 1, 
3, 5, and 7 after treatment with anesthesia over 
intramuscular dose of ketamine HCl. The lower jaw 
was was taken out for making tissue preparations. 
The mandible was fixated with 10% formalin 
buffer solution and decalcified using 10% EDTA 
pH 7.4 for 30 days. The samples were were then 
dehydrated by soaking them in multilevel alcohol, 
followed by a purifying substance. They were 
inserted into liquid paraffin to make blocks. The 
position of the samples was was arranged in 
such a way so that when it was was cut, it would 
obtain longitudinal pieces. Next, the paraffin 
block was cut into 4 µm thick with a microtome 
to be stained using HE and as thick as 5 µm to 
be stained with immunohistochemical anti-NF-
kB mouse monoclonal antibody NF-κB and IgG 
as the secondary antibody. The observation of 
inflammatory infiltration density was carried out by 
assessing 10 fields of view in the epithelial layer 
and gingival sulcus connective tissue based on 
the following parameters: “Absent”, if in 10 fields, 
the field of view did not show the presence of 
inflammatory cells; “low”, if there were at least 5 
fields showing infiltrates of inflammatory cells that 
occupied <50% of the field of view; “moderate”, if 
there were at least 5 fields showing infiltrates of 
inflammatory cells that occupied >50% of the field of 
view; and “dense”, if all (10) fields evaluated showed 
an inflammatory cephalic infiltrate occupying  >90% 
of the field of view.11 Rating of the number of cells 
undergoing NF-κB activation was carried out by 
calculating the number of inflammatory infiltrate 
cells experiencing NF-κB that was was brown color 
on the cell nucleus. The observations were made 
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on 2 view fields, namely the base of gingival sulcus 
and gingival connective tissue.
The data of inflammatory infiltrate density 
were ordinal. Furthermore, the data were tested by 
the Kruskal Wallis test and with the Mann Whitney 
post hoc test. Data on the number of cells that 
experience NF-κB activation were nominal. The 
data were tested by a two-way analysis of variance 
(ANOVA) followed by a post­hoc LSD test. 
Table 2. Kruskal Wallis test results for the density of inflammatory infiltrates in the five treatment groups during the 
observation period (days 1, 3, 5, 7)
Table 1. Level of inflammatory infiltrates in the five treatment groups during the observation period (Days 1, 3, 5, 7) 
 
 
 
Table 2. Kruskal Wallis test results for the density of inflammatory infiltrates in the five treatment groups during the observation period 
(days 1, 3, 5, 7) 
 
         Description: * significantly different at p <0.05 
 
 
Table 3. Mann Whitney post hoc density level of inflammatory infiltrates in the five treatment groups on day 5 and 7 
 
Group p value Day 5 Day 7 
Momordica charantia extract 500 mg/kg BW- 250 mg/kg BW 1.00 0.32 
Momordica charantia extract 500 mg/kg BW- 100 mg/kg BW 0.19 0.32 
Momordica charantia extract 500 mg/kg BW-Ibuprofen 100 mg/kg BW 1.00 0.32 
Momordica charantia extract 500 mg/kg BW-Aquades 0.02* 0.01* 
Momordica charantia extract 250 mg/kg BW-100 mg/kg BW 0.19 1.00 
Momordica charantia extract 250 mg/kg BW-Ibuprofen 100 mg/kg BW 1.00 1.00 
Momordica charantia extract 250 mg/kg BW-Aquades 0.02* 0.02* 
Momordica charantia extract 100 mg/kg BW-Ibuprofen 100 mg/kg BW 0.19 1.00 
Momordica charantia extract 100 mg/kg BW-Aquades 0.04* 0.02* 
Ibuprofen 100 mg/kg BW-Aquades 0.02* 0.02* 
            Description: * significantly different at p<0.05 
 
 
 
 
 
 
 
Group Density Day 1 Day 3 Day 5 Day 7 
Momordica charantia  
extract  
500 mg/kg BW 
Low 0 (0%) 1 (25%) 3 (75%) 4 (100%) 
Moderate 1 (25%) 2 (50%) 1 (25%) 0 (0%) 
Dense 3 (75%) 1 (25%) 0 (0%) 0 (0%) 
Bitter gourd extract 
 250 mg/kg BW 
Low  0 (0%) 1 (25%) 3 (75%) 3 (75%) 
Moderate  1 (25%) 2 (50%) 1 (25%) 1 (25%) 
Dense  3 (75%) 1 (25%) 0 (0%) 0 (0%) 
Bitter gourd extract 
 100 mg/kg BW 
Low  0 (0%) 0 (0%) 1 (25%) 3 (75%) 
Moderate  2 (50%) 3 (75%) 3 (75%) 1 (25%) 
Dense  2 (50%) 1 (25%) 0 (0%) 0 (0%) 
Ibuprofen 100 mg/kg BW 
Low  0 (0%) 1 (25%) 3 (75%) 3 (75%) 
Moderate  2 (50%) 3 (75%) 1 (25%) 1 (25%) 
Dense  2 (50%) 0 (0%) 0 (0%) 0 (0%) 
Aquades 
Low  0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Moderate  1 (25%) 1 (25%) 1 (25%) 1 (25%) 
Dense  3 (75%) 3 (75%) 3 (75%) 3 (75%) 
Group  
Day 1 Day 3 Day 5 Day 7 
Mean 
rank p 
Mean 
rank p 
Mean 
rank  p 
Mean 
rank  P 
Momordica 
charantia extract 
500 mg/kg BW 
11.50 
0.87 
9.38 
0.26 
7.63 
0.03* 
7.00 
0.02* 
Momordica 
charantia extract 
250 mg/kg BW 
11.50 9.38 7.63 9.13 
Momordica 
charantia extract 
100 mg/kg BW 
9.00 11.13 11.88 9.13 
Ibuprofen 100 
mg/kg BW 9.00 7.25 7.63 9.13 
Aquades 11.50 15.38 17.75 18.13 
p
Description: * significantly different at p<0.05
Table 1. Level of inflammatory infiltrates in the five treatment groups during the observation period (Days 1, 3, 5, 7)
RESULTS
The results showed that the density level 
inflammatory cell infiltrates in all treatment groups 
decreased over time, except in the group of rats 
which were only given aquades. This indicates 
that the inflammatory process decreases with the 
administration of ethanolic extract of Momordica 
charantia and ibuprofen (Table 1).
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Description: * significantly different at p <0.05 
 
Table 3. Mann Whitne post hoc density level of inflammatory infiltrates in the five treatment groups on day 5 and 7 
Group p value Day 5 Day 7 
Momordica charantia extract 500 mg/kg BW- 250 mg/kg BW 1.00 0.32 
Momordica charantia extract 500 mg/kg BW- 100 mg/kg BW 0.19 0.32 
Momordica charantia extract 500 mg/kg BW-Ibuprofen 100 mg/kg BW 1.00 0.32 
Momordica charantia extract 500 mg/kg BW-Aquades 0.02* 0.01* 
Momordica charantia extract 250 mg/kg BW-100 mg/kg BW 0.19 1.00 
Momordica charantia extract 250 mg/kg BW-Ibuprofen 100 mg/kg BW 1.00 1.00 
Momordica charantia extract 250 mg/kg BW-Aquades 0.02* 0.02* 
Momordica charantia extract 100 mg/kg BW-Ibuprofen 100 mg/kg BW 0.19 1.00 
Momordica charantia extract 100 mg/kg BW-Aquades 0.04* 0.02* 
Ibuprofen 100 mg/kg BW-Aquades 0.02* 0.02* 
Description: * significantly different at p<0.05 
 
 
 
Group Density Day 1 Day 3 Day 5 Day 7 
Momordica 
charantia  
extract  
500 mg/kg BW 
Low    0 (0%)    1 (25%) 3 (75%)   4 (100%) 
Moderate    1 (25%)    2 (50%) 1 (25%)   0 (0%) 
Dense 
   3 (75%)    1 (25%) 0 (0%)   0 (0%) 
Bitter gourd 
extract 
250 mg/kg BW 
Low     0 (0%)    1 (25%) 3 (75%)   3 (75%) 
Moderate     1 (25%)    2 (50%) 1 (25%)   1 (25%) 
Dense     3 (75%)    1 (25%) 0 (0%)   0 (0%) 
Bitter gourd 
extract 
100 mg/kg BW 
Low     0 (0%)    0 (0%) 1 (25%)   3 (75%) 
Moderate     2 (50%)    3 (75%) 3 (75%)   1 (25%) 
Dense     2 (50%)    1 (25%) 0 (0%)   0 (0%) 
Ibuprofen 100 
mg/kg BW 
Low     0 (0%)    1 (25%) 3 (75%)   3 (75%) 
Moderate     2 (50%)    3 (75%) 1 (25%)   1 (25%) 
Dense     2 (50%)    0 (0%) 0 (0%)   0 (0%) 
Aquades 
Low     0 (0%)    0 (0%) 0 (0%)   0 (0%) 
Moderate     1 (25%)    1 (25%) 1 (25%)   1 (25%) 
Dense     3 (75%)    3 (75%) 3 (75%)   3 (75%) 
Group  
Day 1 Day 3 Day 5 Day 7 
Mean 
rank p 
Mean 
rank p 
Mean 
rank  p 
Mean 
rank  P 
Momordica 
charantia extract 
500 mg/kg BW 
11.50 
0.87 
9.38 
0.26 
7.63 
0.03* 
7.00 
0.02* 
Momordica 
charantia extract 
250 mg/kg BW 
11.50 9.38 7.63 9.13 
Momordica 
charantia extract 
100 mg/kg BW 
9.00 11.13 11.88 9.13 
Ibuprofen 100 
mg/kg BW 9.00 7.25 7.63 9.13 
Aquades 11.5  15.38 1 .75 18.  
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Table 3. Mann Whitney post hoc density level of inflammatory infiltrates in the five treatment groups on day 5 and 7
Group
p value
Day 5 Day 7
Momordica charantia extract 500 mg/kg BW- 250 mg/kg BW 1.00 0.32
Momordica charantia extract 500 mg/kg BW- 100 mg/kg BW 0.19 0.32
Momordica charantia extract 500 mg/kg BW-Ibuprofen 100 mg/kg BW 1.00 0.32
Momordica charantia extract 500 mg/kg BW-Aquades 0.02* 0.01*
Momordica charantia extract 250 mg/kg BW-100 mg/kg BW 0.19 1.00
Momordica charantia extract 250 mg/kg BW-Ibuprofen 100 mg/kg BW 1.00 1.00
Momordica charantia extract 250 mg/kg BW-Aquades 0.02* 0.02*
Momordica charantia extract 100 mg/kg BW-Ibuprofen 100 mg/kg BW 0.19 1.00
Momordica charantia extract 100 mg/kg BW-Aquades 0.04* 0.02*
Ibuprofen 100 mg/kg BW-Aquades 0.02* 0.02*
Description: * significantly different at p<0.05
Table 4. Kruskal Wallis test results of of inflammatory infiltrate density levels during observation days (day 1, 3, 5, and 
7) in each group
Day
Momordica 
charantia extract 
500 mg/kg BW
Momordica 
charantia extract 
250 mg/kg BW
Momordica 
charantia extract 
100 mg/kg BW
Ibuprofen 
100 mg/kg BW Aquades
Mean 
rank p
Mean 
rank p
Mean 
rank p
Mean 
rank p
Mean 
rank p
Day 1 13.50
0.02*
13.38
0.03*
12.00
0.04*
13.25
0.04*
8.50
1.00Day 3 10.00 9.63 10.50 9.25 8.50
Day 5 6.00 5.50 7.38 5.75 8.50
Day 7 4.50 5.50 4.13 5.75 8.50
Description: * significantly different at p<0.05
Table 5. The results of the Mann Whitney post hoc test of the density level of the inflammatory infiltrate between the 
observation days in each treatment group
Day
p value 
 
Momordica 
charantia extract 
250 mg/kg BW
Momordica 
charantia extract 
100 mg/kg BW
Ibuprofen 
100 mg/kg BW
Aquades
Day 1-3 0.16 0.16 0.50 0.01* 1.00
Day 1-5 0.02* 0.02* 0.01* 0.03* 1.00
Day 1-7 0.01* 0.02* 0.03* 0.03* 1.00
Day 3-5 0.156 0.16 0.19 0.19 1.00
Day 3-7 0.04* 0.16 0.04* 0.19 1.00
Day 5-7 0.32 1.00 0.19 1.00 1.00
Description: * significantly different at p<0.05
The test results of the data analysis in Table 2 
with Kruskal Wallis show a value of p>0.05 on day 
1 and 3, whereas on days 5 and 7 p was <0.05. 
This means that the density of inflammatory infiltrate 
differed significantly on days 5 and 7 in various 
groups. 
The results of Mann-Whitney post­hoc test 
on the 5th and 7th day showed that there were 
significant differences in inflammatory density 
between groups of various concentrations of 
Momordica charantia extract and aquades, and 
between ibuprofen 100 mg/kg BW with aquades 
(p<0.05), whereas the the groups of various 
concentrations of Momordica charantia extract and 
ibuprofen 100 mg/kg BW showed no significant 
differences (p>0.05). This indicates that after the 
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administration of ethanolic extract of Momordica 
charantia, the density of inflammatory infiltrate 
on days 5 and 7 was significantly different when 
compared to aquades, but not significantly different 
when compared to ibuprofen. Thus, it can be 
interpreted that the effect of giving Momordica 
charantia is the same as ibuprofen as a positive 
control (Table 3).
The density of the inflammatory infiltrate 
decreased from the initial observation (day 1) to 
the end of observation (day 7) in all groups, except 
aquades. Analysis of differences in the density 
of inflammatory infiltrates based on observation 
days in each group was carried out using the 
Kruskal Wallis test. The Kruskal Wallis test results 
in Table 4 show significant values (p<0.05) in all 
groups, except for aquades groups (p=1.00). This 
means that the density of inflammatory infiltrates is 
significantly different from the beginning to the end 
of the observation, except in the aquades group.
The Mann Whitney post hoc test as presented 
in Table 5 shows that there are significant differences 
(p<0.05) between the Momordica charantia group 
of 500 mg/kg BW, 250 mg/kg BW, 100 mg/kg BW 
and ibuprofen 100 mg/kg BW on day 1 with 5, and 
day 1 with 7. This means that a significant decrease 
in the density of inflammatory infiltrate occurs at 5 
days after giving Momordica charantia extract of of 
500 mg/kg BW, 250 mg/kg BW, 100 mg/kg BW and 
ibuprofen 100 mg/kg BW. A significant decrease in 
the density of inflammatory infiltrates was found in 
the ibuprofen group of of 100 mg/kg BW on day 1 
with 3, and the Momordica charantia group 500 mg/
kg BW and 100 mg/kg BW on day 3 with 7. While 
in group of of 250 mg/kg BW and 100 mg/kg BW, 
there was no significant difference (p>0.05). This 
highlight that in this group there was no decrease 
in the density of inflammatory infiltrates during the 
observation period.
The observation of the number of activated 
NF-κB cells showed a decrease with increasing 
observation days in the group of periodontitis 
rats treated with Momordica charantia extract of 
500 mg/kg BW, 250 mg/kg BW, 100 mg/kg BW, 
ibuprofen, and aquades. The group of rats given 
the Momordica charantia fruit ethanolic extract of 
500 mg/kg BW showed the least number of cells 
with activated NF-κB compared to the other groups. 
The group of rats given the ethanolic extract of 
Momordica charantia of 250 mg/kg BW showed 
a greater number of NF-κB cells compared to the 
group that received 500 mg/kg BW of Momordica 
charantia extract, but less than group with 100 mg/
kg BW. The group of rats given ibuprofen of 100 
mg/kg BW showed the number of cells with NF-
κB activation which was almost the same as the 
group of rats given 100 mg/kg BW of Momordica 
charantia ethanolic extract. This shows that the 
higher the concentration of Momordica charantia 
ethanolic extract given, the less the number of cells 
that experience NF-κB activation (Figure 1,2).
The two-way ANOVA test results in Table 6 
indicate that there were differences in the number 
of inflammatory cells that experienced NF-κB 
Figure 1. Number of inflammatory cells that have NF-κB activation in 5 treatment groups during the observation period
 
 
 
 
 
 
 
Figure 1. Number of inflammatory cells that have NF-κB activation in 5 treatment groups during the observation period 
 
 
 
 
 
 
 
 
 
 
 
Ibuprofen 100 mg/kg 
BW 
Momordica charantia 
extract 100 mg/kg BW 
 
Momordica charantia 
extract 250 mg/kg BW 
 
Momordica charantia 
extract 500 mg/kg BW 
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activation which were significant (p<0.05) between 
groups, days of observation, and interactions 
between treatment groups and observation days. 
This means that the day of observation and 
treatment has a significant effect on the number of 
inflammatory cells that undergo NF-κB activation.
To compare the differences between treatment 
groups, a post hoc LSD test was done and can be 
seen in Table 7. The results of the post hoc LSD test 
in Table 7 show that there are significant differences 
in the number of cells that experienced NF-κB 
activation between treatment groups during the 
observation day (p<0.05), except the Momordica 
charantia extract group of of 100 mg/kg BW with 
100 mg/kg BW ibuprofen on day 1 and 3, and 
Momordica charantia extract group with 250 mg/
kg BW and 100 mg/kg BW on day 7 (p>0.05). This 
shows that the number of cells undergoing NF-κB 
activation between treatment groups experienced 
a statistically significant decrease, except for 
the group of Momordica charantia of 100 mg/kg 
compared to ibuprofen of of 100 mg/kg BW on days 
1 and 3, and Momordica charantia group of 250 mg/
kg BW and 100 mg/kg BW on day 7.
The results of the post hoc LSD test in Table 
8 show that there are significant differences in the 
number of cells that experienced NF-κB activation 
between the observation days in each group, 
which is indicated by the value (p<0.05). Thus, it 
can be concluded that the average number of cells 
experiencing NF-κB activation showed a significant 
decrease over time in various treatment groups.
Table 6. The summary of two-way ANOVA test results for the 
number of inflammatory cells that undergo NF-κB activation
Source F p value
Group 348.03 0.00*
Day 3630.29 0.00*
Group-day 12.31 0.00*
Description: * significantly different at p<0.05
 
 
 
 
 
 
 
 
 
 
 
 
(A)                                                                 (B)                                                               
(C) 
 
Figure 2 
 
Table 6. The summary of two-way ANOVA test results for the number of inflammatory cells that undergo NF-κB activation 
 
Source F p value 
Group  348.03 0.00* 
Day  3630.29 0.00* 
Group-day  12.31 0.00* 
Description: * significantly different at p<0.05 
 
Table 7. Post ho  LSD test results for the number of inflammatory cells that experienc d NF-κB activation betwe n tr atment groups 
 
Group  
p value 
Day 1 Day 3 Day 5 Day 7 
Momordica charantia extract of of 500 mg/kg- 250 mg/kg 0.00* 0.00* 0.00* 0.00* 
Momordica charantia extract of of 500 mg/kg- 100 mg/kg 0.00* 0.00* 0.00* 0.00* 
Momordica charantia extract of of 500 mg/kg- ibuprofen 100 mg/kg 0.00* 0.00* 0.00* 0.00* 
Momordica charantia extract of of 500 mg/kg- aquades 0.00* 0.00* 0.00* 0.00* 
Momordica charanti  extract of f 250 mg/kg- 100 mg/kg 0.00* 0.00* 0.00* 0.05 
M mordica charantia extract of of 250 mg/kg- ibuprofen 100 mg/kg 0.00* 0.00* 0.00* 0.00* 
Momordica charantia extract of of 250 mg/kg- aquades 0.00* 0.00* 0.00* 0.00* 
Momordica charantia extract of of 100 mg/kg- ibuprofen 100 mg/kg 0.24 0.33 0.02* 0.02* 
Momordica charantia extract of of100 mg/kg- aquades 0.00* 0.00* 0.00* 0.00* 
Ibuprofen of of 100 mg/kg- aquades 0.00* 0.03* 0.00* 0.00* 
 
Description: * significantly different at p<0.05 
 
 
Table 8. Results of the post hoc LSD number of inflammatory cells that undergo NF-κB activation between observation days 
 
Day 
p value 
Momordica 
charantia extract 
500 mg/kg 
Momordica 
charantia extract 
250 mg/kg 
Momordica 
charantia extract 
100 mg/kg 
Ibuprofen 
100 mg/kg Aquades 
Day 1-3 0.00* 0.00* 0.00* 0.00* 0.00* 
Day 1-5 0.00* 0.00* 0.00* 0.00* 0.00* 
Day 1-7 0.00* 0.00* 0.00* 0.00* 0.00* 
Day 3-5 0.00* 0.00* 0.00* 0.00* 0.02* 
Day 3-7 0.00* 0.00* 0.00* 0.00* 0.00* 
Day 5-7 0.00* 0.00* 0.00* 0.00* 0.00* 
 
Description: * significantly different at p<0.05 
50 µm 50 µm 50 µm 
 (A) (B) (C)
Figure 2. Immunohistochemical features of inflammatory cells that experience activation of NF-κB p50 rat gingival tissue on day 
7 are shown by arrows (red), while those with arrows (blue) are for are for. (A) Aquades group; (B) bitter gourd extract of of 500 
mg/kg BB; (C) ibuprofen 100 mg/kg BB
Table 7. Post hoc LSD test results for the number of inflammatory cells that experienced NF-κB activation between treatment groups
Group 
p value
Day 1 Day 3 Day 5 Day 7
Momordica charantia extract of of 500 mg/kg- 250 mg/kg 0.00* 0.00* 0.00* 0.00*
Momordica charantia extract of of 500 mg/kg- 100 mg/kg 0.00* 0.00* 0.00* 0.00*
Momordica charantia extract of of 500 mg/kg- ibuprofen 100 mg/kg 0.00* 0.00* 0.00* 0.00*
Momordica charantia extract of of 500 mg/kg- aquades 0.00* 0.00* 0.00* 0.00*
Momordica charantia extract of of 250 mg/kg- 100 mg/kg 0.00* 0.00* 0.00* 0.05
Momordica charantia extract of of 250 mg/kg- ibuprofen 100 mg/kg 0.00* 0.00* 0.00* 0.00*
Momordica charantia extract of of 250 mg/kg- aquades 0.00* 0.00* 0.00* 0.00*
Momordica charantia extract of of 100 mg/kg- ibuprofen 100 mg/kg 0.24 0.33 0.02* 0.02*
Momordica charantia extract of of100 mg/kg- aquades 0.00* 0.00* 0.00* 0.00*
Ibuprofen of of 100 mg/kg- aquades 0.00* 0.03* 0.00* 0.00*
Description: * significantly different at p<0.05
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Table 8. Results of the post hoc LSD number of inflammatory cells that undergo NF-κB activation between observation days
Day
p value
Momordica charantia 
extract
500 mg/kg
Momordica              
charantia extract         
250 mg/kg
Momordica 
charantia extract 
100 mg/kg
Ibuprofen
100 mg/kg
Aquades
Day 1-3 0.00* 0.00* 0.00* 0.00* 0.00*
Day 1-5 0.00* 0.00* 0.00* 0.00* 0.00*
Day 1-7 0.00* 0.00* 0.00* 0.00* 0.00*
Day 3-5 0.00* 0.00* 0.00* 0.00* 0.02*
Day 3-7 0.00* 0.00* 0.00* 0.00* 0.00*
Day 5-7 0.00* 0.00* 0.00* 0.00* 0.00*
Description: * significantly different at p<0.05
The two-way ANOVA test results in Table 
6 showed that there were significant differences 
(p<0.05) of the number of inflammatory cells 
activated by NF-κB between groups, observation 
days and interactions between treatment groups 
and observation days. This means that the day of 
observation and treatment has a significant effect 
on the number of inflammatory cells undergoing 
NF-κB activation. To compare between treatment 
groups continued with LSD post hoc test which can 
be seen in Table 7, while to compare between days 
of observation can be seen in Table 8. 
The post hoc LSD test results in Table 7 
show that the number of cells undergoing NF-κB 
activation between treatment groups experienced 
a statistically significant decrease, except for the 
bitter melon group 100 mg/kg BW compared with 
ibuprofen 100 mg/kg BW on day 1 and 3rd, and 
bitter melon group 250 mg/kg BW with bitter melon 
100 mg/kg BW on the 7th day. The post hoc LSD 
test results in Table 8 show that there is a significant 
difference in the number of cells undergoing NF-
κB activation between days of observation in each 
group, which is indicated by p values  <0.05. 
DISCUSSION
Periodontitis is an infectious disease caused 
by interactions between periodontopathogenic 
bacteria and the body’s immune system, which is 
characterized by junctional epithelium migration to 
the apical, loss of connective tissue attachment, 
and damage of periodontal ligament and alveolar 
bone. Induction of periodontitis in this study was 
obtained by insertion of of silk ligature diameter of 
of 3.0 around the rats’ mandibular incisor.12 After silk 
ligature insertion for 14 days, rats’ gingiva showed a 
clinical changes in the form of reddish discoloration, 
bleeding, edema, and gingival recession which is 
clinical signs of periodontitis. Insertion of ligation can 
trigger plaque accumulation and micro ulceration in 
the sulcular epithelium.13
Inflammation is the body’s defense response 
involving host cells, blood vessels, proteins, and 
several mediators that aim to eliminate the cause 
of cell damage and begin the healing process. 
Pathological conditions in the inflammatory process 
are characterized by the release of inflammatory 
mediators by inflammatory cells, causing tissue 
damage.14 The release of inflammatory mediators 
is regulated by NF-κB which acts as a transcription 
factor. Activators of NF-κB such as LPS, TNFα, and 
IL-1β are often found in people with periodontitis. 
These molecules are responsible for the immune 
and inflammatory responses that cause damage 
to soft tissue and bone in the development of 
periodontitis.15
The cells that were activated by NF-kB on 
the 1st day of observation were found in large 
numbers in all treatment groups. This is thought to 
be bacterial invasion and LPS in the tissue causing 
NF-κB activation in the gingival sulcus epithelial 
cells and subsequently increasing the secretion of 
cytokines in the activation of inflammatory cells.14 
The number of cells undergoing NF-κB activation 
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have decreased over time. This might be due to due 
to Charantoside c and Momordicoside g contained 
in Momordica charantia that that prevent NF-κB 
activation stimulated by TNF a.7 If NF-κB activation 
is prevented, the level of inflammatory mediators in 
the tissue will decrease.8
The density level of inflammatory infiltrates in 
all observation groups showed a decrease during 
the observation period, except for the aquades 
group. The number of cells undergoing NF-κB 
activation has decreased during the observation 
day and this phenomenon occurs in all groups. 
This is likely to occur because the inflammatory 
molecular biology process decreases in response to 
the administration of ethanolic extract of Momordica 
charantia fruit as an anti-inflammatory substance. 
The results of this study are corresponding with the 
research conducted by Chao et al. done to sepsis 
rats. The study showed that administration of bitter 
gourd (Momordica charantia) in sepsis rats resulted 
in expression decrease of COX-2 protein, iNOS, 
NF-κB, and inflammatory responses during the 
observation period.8
The anti-inflammatory ef fec tiveness of 
ethanolic extract of Momordica charantia 500 mg/kg 
BW is the best compared to the ethanolic extract of 
bitter gourd fruit 250 mg/kg BW, 100 mg/kg BW, and 
ibuprofen 100 mg/kg BW. The results of this study 
are corresponding with the research conducted by 
Ullah M et al, which showed that the administration 
of ethanolic extract of bitter gourd with 500 mg/
kg BW had an anti-inflammatory effect better than 
that of the smaller doses.16 It is possiblyy due to 
the greater number of active substances acting as 
anti-inflammatory agents. Thus, the administration 
of ethanolic extract of Momardica charantia of 
of 500 mg/kg BW is is recommended as an anti-
inflammatory substance in periodontitis. The use 
of the ethanolic extract of the Momordica charantia 
until a dose of 2000 mg/kg BW has no toxic effects 
and behavior changes, so it is is considered a safe 
herbal of of anti-inflammatory drug.16
Ibuprofen as an anti-inflammatory has several 
effects, such as preventing PGE2 synthesis, 
leukocyte function, suppressing migration of 
neutrophils and IFN-γ stimulated macrophages, 
decreasing levels of NF-κB, I-κB, and κB kinase (IKK) 
inhibitors. The results of the study showed that after 
giving ibuprofen of of 100 mg/kg BW, the density 
of inflammatory infiltrates decreased over time. 
This is in accordance with the research conducted 
by Rainsford KD, that ibuprofen can reduce levels 
of IL-1β and IL-6 on the results of microsrodialysis 
after administration of 800 mg ibuprofen.17
CONCLUSION
Giving ethanolic extract of Momordica charantia 
decreases the density of inflammatory infiltrates, 
and prevents the activation of NF-κB in rats’ gingiva 
inflected by periodontitis. The most effective 
concentration of ethanolic extract of Momordica 
charantia fruit that has an anti-inflammatory effect 
is 500 mg/kg BW. The best anti-inflammatory effect 
was found on the 7th day.
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